American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

November 18, 2020

Newsletter Sponsor

Manufacturing Viral Vector Vaccines

Viral vector-based vaccines constitute a promising part of the biopharmaceutical pipeline. Some estimates show that half of the front runners of vaccine candidates for COVID-19 have used the viral vector platform. Moreover, this is a complex platform with more than 40 vectors being used for both gene therapy and vaccines. Watch this video to learn how vaccines are manufactured using a viral vector platform.

	Industry News

GenScript Receives EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit
GenScript announced the FDA has granted EUA for the cPass SARS-CoV-2 Neutralization Antibody ... read more »

BioMarin Expands Vosoritide Clinical Program
BioMarin announced the Company is expanding its clinical program for vosoritide, an investigational ... read more »

Calquence Approved in EU for Chronic Lymphocytic Leukemia
Calquence, a selective BTK inhibitor, has been approved in the EU for chronic lymphocytic leukemia. read more »

PhoreMost, Oxford Biomedica Announce Gene Therapy Discovery Collaboration
PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-... read more »

Immutep Announces Australian Patent Grant for IMP701 Antibody
Immutep has announced the grant of patent no. 2015229103 entitled “Antibody molecules to LAG-3 and ... read more »

Pierre Fabre Initiates Trial for Monoclonal Antibody Targeting VISTA Checkpoint in Solid Tumors
Pierre Fabre announced the initiation of an international Phase I clinical study in patients with ... read more »

	QC Corner

QC Corner: Current Bacterial Endotoxins Test(BET) and its Intended Use
QC Corner: Current Bacterial Endotoxins Test(BET) and its Intended Use read more »

The Human Microbiome: What It Is, Why It Is Important and Opportunities for Microbiome-Based Therapeutics
The human body is home to a huge and diverse community of microorganisms, consisting of bacteria, ... read more »

	Infographic

Points to Consider When Choosing Your CDMO for Oral Solid Dosage Commercialization
How to choose the right CDMO to advance your OSD product through development and into manufacturing. read more »

	Featured Articles

Total Organic Carbon (TOC): Back to Basics Total organic carbon (TOC) and conductivity data are used in various applications to demonstrate equipment cleanliness, purified water chemical purity... read more »

Polysorbate, the Good, the Bad and the Ugly Polysorbate (PS) refers to a family of amphipathic, nonionic surfactants that is derived from ethoxylated sorbitan or isosorbide (a derivative of ... read more »

	Featured Video

First Patient Dosed in DUR-928 Study in COVID-19 Patients with Acute Liver, Kidney Injury
DURECT has dosed the first patient in its randomized, double-blind, placebo-controlled, multi-center Phase 2 study to evaluate the safety and efficacy... watch »

On-Demand Webinar: Advancements in the Characterization of Pharmaceuticals by DSC
In this webinar, we will explore the use of new technologies and some advanced DSC techniques of the analysis of pharmaceutical materials to better ... watch »

	Featured Products

FTPA2000-260PH Multi-point FT-NIR Analyzer
read more »

APAF-BP AdvantaFlex™ Biopharmaceutical Grade TPE Tubing
read more »

	Featured Whitepaper

White Paper: Optimizing the Bio-Rad NGC Chromatography System for Cryo-EM Applications for High-Resolution and Low-Volume SEC
Structural biology is the three-dimensional study of complex biological molecules, like proteins, to determine their structures at atomic resolution. read more »

eBook: Lipid Technologies: Helping to Develop the Next Generation of Pharmaceuticals
The FDA recently issued guidance intended to curtail the use of medically important antibiotics in agricultural applications. read more »

	Events

Ophthalmic Drugs Conference
Kensington, London – 11/23/2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd-24th of November 2020, in London. The global ophthalmic ... event details »

7th Microbiome and Probiotics R&D and Business Collaboration Forum
Rotterdam, The Netherlands – 12/02/2020
Microbiome and Probiotics R&D and Business Collaboration Forum brings together 400+ industry, academic, and investment leaders to discuss the latest ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA